>AT3G28345.1 | ABC transporter family protein
MGKEEEKESGRNKMNCFGSVRSIFMHADGVDWLLMGLGLIGAVGDGFTTPLVLLITSKLM
NNIGGSSFNTDTFMQSISKNSVALLYVACGSWVVCFLEGYCWTRTGERQTARMREKYLRA
VLRQDVGYFDLHVTSTSDVITSVSSDSFVIQDVLSEKLPNFLMSASTFVGSYIVGFILLW
RLAIVGLPFIVLLVIPGLMYGRALISISRKIREEYNEAGFVAEQAISSVRTVYAFSGERK
TISKFSTALQGSVKLGIKQGLAKGITIGSNGITFAMWGFMSWYGSRMVMYHGAQGGTVFA
VAAAIAIGGVSLGGGLSNLKYFFEAASVGERIMEVINRVPKIDSDNPDGHKLEKIRGEVE
FKNVKFVYPSRLETSIFDDFCLRVPSGKTVALVGGSGSGKSTVISLLQRFYDPLAGEILI
DGVSIDKLQVKWLRSQMGLVSQEPALFATTIKENILFGKEDASMDDVVEAAKASNAHNFI
SQLPNGYETQVGERGVQMSGGQKQRIAIARAIIKSPTILLLDEATSALDSESERVVQEAL
ENASIGRTTILIAHRLSTIRNADVISVVKNGHIVETGSHDELMENIDGQYSTLVHLQQIE
KQDINVSVKIGPISDPSKDIRNSSRVSTLSRSSSANSVTGPSTIKNLSEDNKPQLPSFKR
LLAMNLPEWKQALYGCISATLFGAIQPAYAYSLGSMVSVYFLTSHDEIKEKTRIYALSFV
GLAVLSFLINISQHYNFAYMGEYLTKRIRERMLSKVLTFEVGWFDRDENSSGAICSRLAK
DANVVRSLVGDRMALVVQTVSAVTIAFTMGLVIAWRLALVMIAVQPVIIVCFYTRRVLLK
SMSKKAIKAQDESSKLAAEAVSNVRTITAFSSQERIMKMLEKAQESPRRESIRQSWFAGF
GLAMSQSLTSCTWALDFWYGGRLIQDGYITAKALFETFMILVSTGRVIADAGSMTTDLAK
GSDAVGSVFAVLDRYTSIDPEDPDGYETERITGQVEFLDVDFSYPTRPDVIIFKNFSIKI
EEGKSTAIVGPSGSGKSTIIGLIERFYDPLKGIVKIDGRDIRSYHLRSLRRHIALVSQEP
TLFAGTIRENIIYGGVSDKIDEAEIIEAAKAANAHDFITSLTEGYDTYCGDRGVQLSGGQ
KQRIAIARAVLKNPSVLLLDEATSALDSQSERVVQDALERVMVGRTSVVIAHRLSTIQNC
DAIAVLDKGKLVERGTHSSLLSKGPTGIYFSLVSLQTTSG*
>AT3G62150.1 | PGP21 (P-GLYCOPROTEIN 21) ATPase coupled to transmembrane movement of substances
MDSVIESEEGLKVDSPNRADAETSNSKIHEEDEKELKTESDLKEEKKKTEKNKQEEDEKT
KTVPFHKLFAFADSFDIILMILGTIGAVGNGLGFPIMTILFGDVIDVFGQNQNSSDVSDK
IAKVALKFVYLGLGTLVAALLQVSGWMISGERQAGRIRSLYLQTILRQDIAFFDVETNTG
EVVGRMSGDTVLIQDAMGEKVGKAIQLVSTFIGGFVIAFTEGWLLTLVMVSSIPLLVMSG
AALAIVISKMASRGQTSYAKAAVVVEQTVGSIRTVASFTGEKQAISNYNKHLVSAYRAGV
FEGASTGLGLGTLNIVIFCTYALAVWYGGKMILEKGYTGGQVLIIIFAVLTGSMSLGQAS
PCLSAFAAGQAAAYKMFEAIKRKPEIDASDTTGKVLDDIRGDIELNNVNFSYPARPEEQI
FRGFSLSISSGSTVALVGQSGSGKSTVVSLIERFYDPQSGEVRIDGINLKEFQLKWIRSK
IGLVSQEPVLFTSSIKENIAYGKENATVEEIRKATELANASKFIDKLPQGLDTMVGEHGT
QLSGGQKQRIAVARAILKDPRILLLDEATSALDAESERIVQEALDRIMVNRTTVVVAHRL
STVRNADMIAVIHQGKIVEKGSHSELLRDPEGAYSQLIRLQEDTKQTEDSTDEQKLSMES
MKRSSLRKSSLSRSLSKRSSSFSMFGFPAGIDTNNEAIPEKDIKVSTPIKEKKVSFFRVA
ALNKPEIPMLILGSIAAVLNGVILPIFGILISSVIKAFFKPPEQLKSDTRFWAIIFMLLG
VASMVVFPAQTIFFSIAGCKLVQRIRSMCFEKVVRMEVGWFDETENSSGAIGARLSADAA
TVRGLVGDALAQTVQNLASVTAGLVIAFVASWQLAFIVLAMLPLIGLNGYIYMKFMVGFS
ADAKEASQVANDAVGSIRTVASFCAEEKVMKMYKKKCEGPMRTGIRQGIVSGIGFGVSFF
VLFSSYAASFYAGARLVDDGKTTFDSVFRVFFALTMAAVAISQSSSLSPDSSKASNAAAS
IFAVIDRESKIDPSDESGRVLDNVKGDIELRHISFKYPSRPDVQIFQDLCLSIRAGKTIA
LVGESGSGKSTVIALLQRFYDPDSGQITLDGVEIKTLQLKWLRQQTGLVSQEPVLFNETI
RANIAYGKGGDATETEIVSAAELSNAHGFISGLQQGYDTMVGERGVQLSGGQKQRVAIAR
AIVKDPKVLLLDEATSALDAESERVVQDALDRVMVNRTTVVVAHRLSTIKNADVIAVVKN
GVIVEKGKHETLINIKDGVYASLVQLHLSAST*
>AT3G28415.1 | P-glycoprotein putative
MKSFGSVRSIFMHANSVDLVLMGLGLIGAVGDGFITPIIFFITGLLLNDIGDSSFGDKTF
MHAIMKNAVALLYVAGASLVICFVGERQASRMREKYLRAVLRQDVGYFDLHVTSTSDVIT
SVSSDTLVIQDVLSEKLPNFLMSASAFVASYIVGFIMLWRLTIVGFPFFILLLIPGLMCG
RALINISRKIREEYNEAGSIAEQAISLVRTVYAFGSERKMISKFSAALEGSVKLGLRQGI
AKGIAIGSNGVTYAIWGFMTWYGSRMVMYHGAKGGTIFAVIICITYGGTSLGRGLSNLKY
FSEAVVAGERIIEVIKRVPDIDSDNPRGQVLENIKGEVQFKHVKFMYSSRPETPIFDDLC
LRIPSGKSVALVGGSGSGKSTVISLLQRFYDPIVGEILIDGVSIKKLQVKWLRSQMGLVS
QEPALFATSIEENILFGKEDASFDEVVEAAKSSNAHDFISQFPLGYKTQVGERGVQMSGG
QKQRISIARAIIKSPTLLLLDEATSALDSESERVVQEALDNATIGRTTIVIAHRLSTIRN
VDVICVFKNGQIVETGSHEELMENVDGQYTSLVRLQIMENEESNDNVSVSMREGQFSNFN
KDVKYSSRLSIQSRSSLFATSSIDTNLAGSIPKDKKPSFKRLMAMNKPEWKHALYGCLSA
VLYGALHPIYAYASGSMVSVYFLTSHDEMKEKTRIYVLLFVGLAVLCFLISIIQQYSFAY
MGEYLTKRIRENILSKLLTFEVSWFDEDENSSGSICSRLAKDANVVRSLVGERVSLLVQT
ISAVSVACTLGLAISWKLSIVMIAIQPVVVGCFYTQRIVLKSISKKAIKAQDESSKLAAE
AVSNIRTITAFSSQERILKLLKMVQEGPQRENIRQSWLAGIVLATSRSLMTCTSALNYWY
GARLIIDGKITSKAFFELFILFVSTGRVIADAGAMTMDLAKGSDAVGSVFAVLDRYTNIE
PEKPDGFVPQNIKGQIKFVNVDFAYPTRPDVIIFKNFSIDIDEGKSTAIVGPSGSGKSTI
IGLIERFYDPLKGIVKIDGRDIRSYHLRSLRQHIGLVSQEPILFAGTIRENIMYGGASDK
IDESEIIEAAKAANAHDFIVTLSDGYDTYCGDRGVQLSGGQKQRIAIARAVLKNPSVLLL
DEATSALDNQSERMVQDALGRLMVGRTSVVIAHRLSTIQNCDTITVLDKGKVVECGTHSS
LLAKGPTGVYFSLVSLQRTRY*
>AT3G28380.1 | PGP17 (P-GLYCOPROTEIN 17) ATP binding / ATPase/ ATPase coupled to transmembrane movement of substances / nucleoside-triphosphatase/ nucleotide binding
MGKEDEKESGRDKMKSFGSIRSIFMHADGVDWILMALGLIGAVGDGFITPVVVFIFNTLL
NNLGTSSSNNKTFMQTISKNVVALLYVACGSWVICFLEGYCWTRTGERQAARMREKYLRA
VLRQDVGYFDLHVTSTSDVITSISSDSLVIQDFLSEKLPNFLMNASAFVASYIVSFILMW
RLTIVGFPFIILLLVPGLMYGRALVSISRKIHEQYNEAGSIAEQAISSVRTVYAFGSENK
MIGKFSTALRGSVKLGLRQGLAKGITIGSNGVTHAIWAFLTWYGSRLVMNHGSKGGTVFV
VISCITYGGVSLGQSLSNLKYFSEAFVAWERILEVIKRVPDIDSNKKEGQILERMKGEVE
FNHVKFTYLSRPETTIFDDLCLKIPAGKTVALVGGSGSGKSTVISLLQRFYDPIAGEILI
DGVSIDKLQVNWLRSQMGLVSQEPVLFATSITENILFGKEDASLDEVVEAAKASNAHTFI
SQFPLGYKTQVGERGVQMSGGQKQRIAIARAIIKSPKILLLDEATSALDSESERVVQESL
DNASIGRTTIVIAHRLSTIRNADVICVIHNGQIVETGSHEELLKRIDGQYTSLVSLQQME
NEESNVNINVSVTKDQVMSLSKDFKYSQHNSIGSTSSSIVTNVSDLIPNDNQPLVPSFTR
LMVMNRPEWKHALYGCLSAALVGVLQPVSAYSAGSVISVFFLTSHDQIKEKTRIYVLLFV
GLAIFSFLVNISQHYGFAYMGEYLTKRIREQMLSKILTFEVNWFDIDDNSSGAICSRLAK
DANVVRSMVGDRMSLLVQTISAVIIACIIGLVIAWRLAIVMISVQPLIVVCFYTQRVLLK
SLSEKASKAQDESSKLAAEAVSNIRTITAFSSQERIIKLLKKVQEGPRRESVHRSWLAGI
VLGTSRSLITCTSALNFWYGGRLIADGKIVSKAFFEIFLIFVTTGRVIADAGTMTTDLAR
GLDAVGSVFAVLDRCTTIEPKNPDGYVAEKIKGQITFLNVDFAYPTRPDVVIFENFSIEI
DEGKSTAIVGTSGSGKSTIIGLIERFYDPLKGTVKIDGRDIRSYHLRSLRKYISLVSQEP
MLFAGTIRENIMYGGTSDKIDESEIIEAAKAANAHDFITSLSNGYDTNCGDKGVQLSGGQ
KQRIAIARAVLKNPSVLLLDEATSALDSKSERVVQDALERVMVGRTSIMIAHRLSTIQNC
DMIVVLGKGKIVESGTHSSLLEKGPTGTYFSLAGIQRTLC*
>AT3G28860.1 | ABCB19 ATPase coupled to transmembrane movement of substances / auxin efflux transmembrane transporter
MSETNTTDAKTVPAEAEKKKEQSLPFFKLFSFADKFDYLLMFVGSLGAIVHGSSMPVFFL
LFGQMVNGFGKNQMDLHQMVHEVSRYSLYFVYLGLVVCFSSYAEIACWMYSGERQVAALR
KKYLEAVLKQDVGFFDTDARTGDIVFSVSTDTLLVQDAISEKVGNFIHYLSTFLAGLVVG
FVSAWKLALLSVAVIPGIAFAGGLYAYTLTGITSKSRESYANAGVIAEQAIAQVRTVYSY
VGESKALNAYSDAIQYTLKLGYKAGMAKGLGLGCTYGIACMSWALVFWYAGVFIRNGQTD
GGKAFTAIFSAIVGGMSLGQSFSNLGAFSKGKAAGYKLMEIINQRPTIIQDPLDGKCLDQ
VHGNIEFKDVTFSYPSRPDVMIFRNFNIFFPSGKTVAVVGGSGSGKSTVVSLIERFYDPN
SGQILLDGVEIKTLQLKFLREQIGLVNQEPALFATTILENILYGKPDATMVEVEAAASAA
NAHSFITLLPKGYDTQVGERGVQLSGGQKQRIAIARAMLKDPKILLLDEATSALDASSES
IVQEALDRVMVGRTTVVVAHRLCTIRNVDSIAVIQQGQVVETGTHEELIAKSGAYASLIR
FQEMVGTRDFSNPSTRRTRSTRLSHSLSTKSLSLRSGSLRNLSYSYSTGADGRIEMISNA
ETDRKTRAPENYFYRLLKLNSPEWPYSIMGAVGSILSGFIGPTFAIVMSNMIEVFYYTDY
DSMERKTKEYVFIYIGAGLYAVGAYLIQHYFFSIMGENLTTRVRRMMLSAILRNEVGWFD
EDEHNSSLIAARLATDAADVKSAIAERISVILQNMTSLLTSFIVAFIVEWRVSLLILGTF
PLLVLANFAQQLSLKGFAGDTAKAHAKTSMIAGEGVSNIRTVAAFNAQSKILSLFCHELR
VPQKRSLYRSQTSGFLFGLSQLALYGSEALILWYGAHLVSKGVSTFSKVIKVFVVLVITA
NSVAETVSLAPEIIRGGEAVGSVFSVLDRQTRIDPDDADADPVETIRGDIEFRHVDFAYP
SRPDVMVFRDFNLRIRAGHSQALVGASGSGKSSVIAMIERFYDPLAGKVMIDGKDIRRLN
LKSLRLKIGLVQQEPALFAATIFDNIAYGKDGATESEVIDAARAANAHGFISGLPEGYKT
PVGERGVQLSGGQKQRIAIARAVLKNPTVLLLDEATSALDAESECVLQEALERLMRGRTT
VVVAHRLSTIRGVDCIGVIQDGRIVEQGSHSELVSRPEGAYSRLLQLQTHRI*
>AT2G36910.1 | ABCB1 (ATP BINDING CASSETTE SUBFAMILY B1) ATPase coupled to transmembrane movement of substances / auxin efflux transmembrane transporter/ calmodulin binding
MDNDGGAPPPPPTLVVEEPKKAEIRGVAFKELFRFADGLDYVLMGIGSVGAFVHGCSLPL
FLRFFADLVNSFGSNSNNVEKMMEEVLKYALYFLVVGAAIWASSWAEISCWMWSGERQTT
KMRIKYLEAALNQDIQFFDTEVRTSDVVFAINTDAVMVQDAISEKLGNFIHYMATFVSGF
IVGFTAVWQLALVTLAVVPLIAVIGGIHTTTLSKLSNKSQESLSQAGNIVEQTVVQIRVV
MAFVGESRASQAYSSALKIAQKLGYKTGLAKGMGLGATYFVVFCCYALLLWYGGYLVRHH
LTNGGLAIATMFAVMIGGLALGQSAPSMAAFAKAKVAAAKIFRIIDHKPTIERNSESGVE
LDSVTGLVELKNVDFSYPSRPDVKILNNFCLSVPAGKTIALVGSSGSGKSTVVSLIERFY
DPNSGQVLLDGQDLKTLKLRWLRQQIGLVSQEPALFATSIKENILLGRPDADQVEIEEAA
RVANAHSFIIKLPDGFDTQVGERGLQLSGGQKQRIAIARAMLKNPAILLLDEATSALDSE
SEKLVQEALDRFMIGRTTLIIAHRLSTIRKADLVAVLQQGSVSEIGTHDELFSKGENGVY
AKLIKMQEAAHETAMSNARKSSARPSSARNSVSSPIMTRNSSYGRSPYSRRLSDFSTSDF
SLSIDASSYPNYRNEKLAFKDQANSFWRLAKMNSPEWKYALLGSVGSVICGSLSAFFAYV
LSAVLSVYYNPDHEYMIKQIDKYCYLLIGLSSAALVFNTLQHSFWDIVGENLTKRVREKM
LSAVLKNEMAWFDQEENESARIAARLALDANNVRSAIGDRISVIVQNTALMLVACTAGFV
LQWRLALVLVAVFPVVVAATVLQKMFMTGFSGDLEAAHAKGTQLAGEAIANVRTVAAFNS
EAKIVRLYTANLEPPLKRCFWKGQIAGSGYGVAQFCLYASYALGLWYASWLVKHGISDFS
KTIRVFMVLMVSANGAAETLTLAPDFIKGGQAMRSVFELLDRKTEIEPDDPDTTPVPDRL
RGEVELKHIDFSYPSRPDIQIFRDLSLRARAGKTLALVGPSGCGKSSVISLIQRFYEPSS
GRVMIDGKDIRKYNLKAIRKHIAIVPQEPCLFGTTIYENIAYGHECATEAEIIQAATLAS
AHKFISALPEGYKTYVGERGVQLSGGQKQRIAIARALVRKAEIMLLDEATSALDAESERS
VQEALDQACSGRTSIVVAHRLSTIRNAHVIAVIDDGKVAEQGSHSHLLKNHPDGIYARMI
QLQRFTHTQVIGMTSGSSSRVKEDDA*
>AT1G02520.1 | PGP11 (P-GLYCOPROTEIN 11) ATPase coupled to transmembrane movement of substances
MNGDGAREGDSVSHEPSTSKSPKEGEETKKEEKSEEKANTVPFYKLFAFADSSDVLLMIC
GSIGAIGNGMSLPFMTLLFGDLIDSFGKNQNNKDIVDVVSKVCLKFVYLGLGTLGAAFLQ
VACWMITGERQAARIRSTYLKTILRQDIGFFDVETNTGEVVGRMSGDTVLIQDAMGEKVG
KFIQLVSTFVGGFVLAFIKGWLLTLVMLTSIPLLAMAGAAMALIVTRASSRGQAAYAKAA
TVVEQTIGSIRTVASFTGEKQAINSYKKFITSAYKSSIQQGFSTGLGLGVMFFVFFSSYA
LAIWFGGKMILEKGYTGGAVINVIIIVVAGSMSLGQTSPCVTAFAAGQAAAYKMFETIKR
KPLIDAYDVNGKVLEDIRGDIELKDVHFSYPARPDEEIFDGFSLFIPSGATAALVGESGS
GKSTVISLIERFYDPKSGAVLIDGVNLKEFQLKWIRSKIGLVSQEPVLFSSSIMENIAYG
KENATVEEIKAATELANAAKFIDKLPQGLDTMVGEHGTQLSGGQKQRIAIARAILKDPRI
LLLDEATSALDAESERVVQEALDRVMVNRTTVIVAHRLSTVRNADMIAVIHRGKMVEKGS
HSELLKDSEGAYSQLIRLQEINKDVKTSELSSGSSFRNSNLKKSMEGTSSVGNSSRHHSL
NVLGLTTGLDLGSHSQRAGQDETGTASQEPLPKVSLTRIAALNKPEIPVLLLGTVAAAIN
GAIFPLFGILISRVIEAFFKPAHELKRDSRFWAIIFVALGVTSLIVSPTQMYLFAVAGGK
LIRRIRSMCFEKAVHMEVAWFDEPQNSSGTMGARLSADATLIRALVGDALSLAVQNVASA
ASGLIIAFTASWELALIILVMLPLIGINGFVQVKFMKGFSADAKSKYEEASQVANDAVGS
IRTVASFCAEEKVMQMYKKQCEGPIKDGIKQGFISGLGFGFSFFILFCVYATSFYAGARL
VEDGKTTFNNVFQVFFALTMAAIGISQSSTFAPDSSKAKVAAASIFAIIDRKSKIDSSDE
TGTVLENVKGDIELRHLSFTYPARPDIQIFRDLCLTIRAGKTVALVGESGSGKSTVISLL
QRFYDPDSGHITLDGVELKKLQLKWLRQQMGLVGQEPVLFNDTIRANIAYGKGSEEAATE
SEIIAAAELANAHKFISSIQQGYDTVVGERGIQLSGGQKQRVAIARAIVKEPKILLLDEA
TSALDAESERVVQDALDRVMVNRTTIVVAHRLSTIKNADVIAVVKNGVIAEKGTHETLIK
IEGGVYASLVQLHMTASN*
>AT2G39480.1 | PGP6 (P-GLYCOPROTEIN 6) ATPase coupled to transmembrane movement of substances
MMISRGLFGWSPPHIQPLTPVSEVSEPPESPSPYLDPGAEHGGTGTAAQADDEEEMEEPE
EMEPPPAAVPFSQLFACADRFDWVLMVFGSVAAAAHGTALIVYLHYFAKIVQVLAFPTDS
DHLISDDQFNRLLELSLTIVYIAGGVFISGWIEVSCWILTGERQTAVIRSKYVQVLLNQD
MSFFDTYGNNGDIVSQVLSDVLLIQSALSEKVGNYIHNMATFISGLIIGFVNCWEIALIT
LATGPFIVAAGGISNIFLHRLAENIQDAYAEAASIAEQAVSYVRTLYAFTNETLAKYSYA
TSLQATLRYGILISLVQGLGLGFTYGLAICSCAMQLWIGRFFVIHHRANGGEIITALFAV
ILSGLGLNQAATNFYSFDQGRIAAYRLFEMISRSSSGTNQEGIILSAVQGNIEFRNVYFS
YLSRPEIPILSGFYLTVPAKKAVALVGRNGSGKSSIIPLMERFYDPTLGEVLLDGENIKN
LKLEWLRSQIGLVTQEPALLSLSIRENIAYGRDATLDQIEEAAKKAHAHTFISSLEKGYE
TQVGKTGLTLTEEQKIKLSIARAVLLDPTILLLDEVTGGLDFEAERVVQEALDLLMLGRS
TIIIARRLSLIRNADYIAVMEEGQLLEMGTHDELINLGNLYAELLKCEEATKLPRRMPVR
NYNDSAAFQAERDSSAGRGFQEPSSPKMAKSPSLQRGHNVFRSQELCFNSEESPNDHSPA
PEKLGENGSSLDVGEKEPTIKRQDSFEMRLPELPKIDIQCPQRQKSNGSDPESPISPLLI
SDPQNERSHSQTFSRPLGHSDDTSASVKVAKDGQHKEPPSFWRLAQLSFPEWLYAVLGSI
GAAIFGSFNPLLAYVIALVVTTYYTSKGSHLREEVDKWCLIIACMGIVTVVANFLQHFYF
GIMGEKMTERVRRMMFSAMLRNEVGWYDEEENSPDTLSMRLANDATFVRAAFSNRLSIFI
QDSFAVIVAILIGLLLGWRLALVALATLPVLTLSAIAQKLWLAGFSKGIQEMHRKASLVL
EDAVRNIYTVVAFCAGNKVMELYRLQLQRILRQSFFHGMAIGFAFGFSQFLLFACNALLL
WYTALSVDRRYMKLSTALTEYMVFSFATFALVEPFGLAPYILKRRRSLASVFEIIDRVPT
IEPDDTSALSPPNVYGSIELKNIDFCYPTRPEVLVLSNFSLKVNGGQTVAVVGVSGSGKS
TIISLIERYYDPVAGQVLLDGRDLKSYNLRWLRSHMGLIQQEPIIFSTTIRENIIYARHN
ASEAEMKEAARIANAHHFISSLPHGYDTHIGMRGVELTQGQKQRIAIARVVLKNAPILLI
DEASSSIESESSRVVQEALDTLIMGNKTTILIAHRVAMMRHVDNIVVLNGGKIVEEGTHD
CLAGKNGLYVRLMQPHFGKNLRRHQLI*
>AT2G47000.1 | ABCB4 (ATP BINDING CASSETTE SUBFAMILY B4) ATPase coupled to transmembrane movement of substances / xenobiotic-transporting ATPase
MASESGLNGDPNILEEVSETKRDKEEEEEVKKTEKKDEEHEKTKTVPFYKLFAFADSFDF
LLMILGTLGSIGNGLGFPLMTLLFGDLIDAFGENQTNTTDKVSKVALKFVWLGIGTFAAA
FLQLSGWMISGERQAARIRSLYLKTILRQDIAFFDIDTNTGEVVGRMSGDTVLIQDAMGE
KVGKAIQLLATFVGGFVIAFVRGWLLTLVMLSSIPLLVMAGALLAIVIAKTASRGQTAYA
KAATVVEQTIGSIRTVASFTGEKQAISNYNKHLVTAYKAGVIEGGSTGLGLGTLFLVVFC
SYALAVWYGGKLILDKGYTGGQVLNIIIAVLTGSMSLGQTSPCLSAFAAGQAAAYKMFET
IERRPNIDSYSTNGKVLDDIKGDIELKDVYFTYPARPDEQIFRGFSLFISSGTTVALVGQ
SGSGKSTVVSLIERFYDPQAGDVLIDGINLKEFQLKWIRSKIGLVSQEPVLFTASIKDNI
AYGKEDATTEEIKAAAELANASKFVDKLPQGLDTMVGEHGTQLSGGQKQRIAVARAILKD
PRILLLDEATSALDAESERVVQEALDRIMVNRTTVVVAHRLSTVRNADMIAVIHQGKIVE
KGSHTELLKDPEGAYSQLIRLQEEKKSDENAAEEQKMSSIESFKQSSLRKSSLGRSLSKG
GSSRGNSSRHSFNMFGFPAGIDGNVVQDQEEDDTTQPKTEPKKVSIFRIAALNKPEIPVL
ILGSISAAANGVILPIFGILISSVIKAFFQPPKKLKEDTSFWAIIFMVLGFASIIAYPAQ
TFFFAIAGCKLVQRIRSMCFEKVVHMEVGWFDEPENSSGTIGARLSADAATIRGLVGDSL
AQTVQNLSSILAGLIIAFLACWQLAFVVLAMLPLIALNGFLYMKFMKGFSADAKKMYGEA
SQVANDAVGSIRTVASFCAEDKVMNMYSKKCEGPMKNGIRQGIVSGIGFGFSFFVLFSSY
AASFYVGARLVDDGKTTFDSVFRVFFALTMAAMAISQSSSLSPDSSKADVAAASIFAIMD
RESKIDPSVESGRVLDNVKGDIELRHVSFKYPARPDVQIFQDLCLSIRAGKTVALVGESG
SGKSTVIALLQRFYDPDSGEITLDGVEIKSLRLKWLRQQTGLVSQEPILFNETIRANIAY
GKGGDASESEIVSSAELSNAHGFISGLQQGYDTMVGERGIQLSGGQKQRVAIARAIVKDP
KVLLLDEATSALDAESERVVQDALDRVMVNRTTIVVAHRLSTIKNADVIAVVKNGVIVEK
GKHDTLINIKDGVYASLVQLHLTAAS*
>AT3G55320.1 | PGP20 (P-GLYCOPROTEIN 20) ATPase coupled to transmembrane movement of substances
MMISRGLFGWSPPHMQPLTPVSEVSEPPESPSPYLDPGAESGGGTGTAAALAEADEEMDD
QDELEPPPAAVPFSQLFACADRFDWVLMIVGSVAAAAHGTALIVYLHYFAKIVDVLAFSN
DSSQQRSEHQFDRLVQLSLTIVYIAGGVFISGWIEVSCWILTGERQTAVIRSKYVQVLLN
QDMSFFDTYGNNGDIVSQVLSDVLLIQSALSEKVGNYIHNMATFISGLVIGFVNCWEIAL
ITLATGPFIVAAGGISNIFLHRLAENIQDAYAEAAGIAEQAISYIRTLYAFTNETLAKYS
YATSLQATLRYGILISLVQGLGLGFTYGLAICSCALQLWIGRFFVHNGRANGGEIIAALF
AVILSGLGLNQAATNFYSFDQGRIAAYRLFEMITRSSSVANQEGAVLASVQGNIEFRNVY
FSYLSRPEIPILSGFYLTVPAKKAVALVGRNGSGKSSIIPLMERFYDPTLGEVLLDGENI
KNLKLEWLRSQIGLVTQEPALLSLSIRENIAYGRDATLDQIEEAAKNAHAHTFISSLEKG
YETQVGRAGLAMTEEQKIKLSIARAVLLNPTILLLDEVTGGLDFEAERIVQEALDLLMLG
RSTIIIARRLSLIKNADYIAVMEEGQLVEMGTHDELINLGGLYAELLKCEEATKLPRRMP
VRNYKESAVFEVERDSSAGCGVQEPSSPKMIKSPSLQRGSGVFRPQELCFDTEESPKAHS
PASEKTGEDGMSLDCADKEPTIKRQDSFEMRLPHLPKVDVQCPQQKSNGSEPESPVSPLL
TSDPKNERSHSQTFSRPLSSPDDTKANGKASKDAQHKESPSFWRLAQLSFPEWLYAVLGS
LGAAIFGSFNPLLAYVIALVVTEYYKSKGGHLREEVDKWCLIIACMGIVTVVANFLQHFY
FGIMGEKMTERVRRMMFSAMLRNEVGWFDDEENSPDTLSMRLANDATFVRAAFSNRLSIF
IQDSFAVIVALLIGLLLGWRLALVALATLPILTLSAIAQKLWLAGFSKGIQEMHRKASLV
LEDAVRNIYTVVAFCAGNKVMELYRMQLQRILRQSYLHGMAIGFAFGFSQFLLFACNALL
LWCTALSVNRGYMKLSTAITEYMVFSFATFALVEPFGLAPYILKRRKSLISVFEIVDRVP
TIEPDDNSALKPPNVYGSIELKNVDFCYPTRPEILVLSNFSLKISGGQTVAVVGVSGSGK
STIISLVERYYDPVAGQVLLDGRDLKLYNLRWLRSHMGLVQQEPIIFSTTIRENIIYARH
NASEAEMKEAARIANAHHFISSLPHGYDTHIGMRGVELTPGQKQRIAIARVVLKNAPIIL
IDEASSSIESESSRVVQEALDTLIMGNKTTILIAHRAAMMRHVDNIVVLNGGRIVEEGTH
DSLAAKNGLYVRLMQPHFGKGLRQHRLI*
>AT1G10680.1 | PGP10 (P-GLYCOPROTEIN 10) ATPase coupled to transmembrane movement of substances
MQPSNDPAIVDMAAAEKEKKRPSVSFLKLFSFADFYDCVLMALGSIGACIHGASVPVFFI
FFGKLINIIGLAYLFPQEASHKVAKYSLDFVYLSVVILFSSWLEVACWMHTGERQAAKIR
KAYLRSMLSQDISLFDTEISTGEVISAITSEILVVQDAISEKVGNFMHFISRFIAGFAIG
FASVWQISLVTLSIVPFIALAGGIYAFVSSGLIVRVRKSYVKANEIAEEVIGNVRTVQAF
TGEEKAVSSYQGALRNTYNYGRKAGLAKGLGLGSLHFVLFLSWALLIWFTSIVVHKGIAN
GGESFTTMLNVVIAGLSLGQAAPDISTFMRASAAAYPIFQMIERNTEDKTGRKLGNVNGD
ILFKDVTFTYPSRPDVVIFDKLNFVIPAGKVVALVGGSGSGKSTMISLIERFYEPTDGAV
MLDGNDIRYLDLKWLRGHIGLVNQEPVLFATTIRENIMYGKDDATSEEITNAAKLSEAIS
FINNLPEGFETQVGERGIQLSGGQKQRISISRAIVKNPSILLLDEATSALDAESEKIVQE
ALDRVMVGRTTVVVAHRLSTVRNADIIAVVGGGKIIESGSHDELISNPDGAYSSLLRIQE
AASPNLNHTPSLPVSTKPLPELPITETTSSIHQSVNQPDTTKQAKVTVGRLYSMIRPDWK
YGLCGTLGSFIAGSQMPLFALGIAQALVSYYMDWETTQNEVKRISILFCCGSVITVIVHT
IEHTTFGIMGERLTLRVRQKMFSAILRNEIGWFDKVDNTSSMLASRLESDATLLRTIVVD
RSTILLENLGLVVTAFIISFILNWRLTLVVLATYPLIISGHISEKIFMQGYGGNLSKAYL
KANMLAGESISNIRTVVAFCAEEKVLDLYSKELLEPSERSFRRGQMAGILYGVSQFFIFS
SYGLALWYGSILMEKGLSSFESVMKTFMVLIVTALVMGEVLALAPDLLKGNQMVVSVFEL
LDRRTQVVGDTGEELSNVEGTIELKGVHFSYPSRPDVTIFSDFNLLVPSGKSMALVGQSG
SGKSSVLSLVLRFYDPTAGIIMIDGQDIKKLKLKSLRRHIGLVQQEPALFATTIYENILY
GKEGASESEVMEAAKLANAHSFISSLPEGYSTKVGERGIQMSGGQRQRIAIARAVLKNPE
ILLLDEATSALDVESERVVQQALDRLMRDRTTVVVAHRLSTIKNSDMISVIQDGKIIEQG
SHNILVENKNGPYSKLISLQQRQRHHP*
>AT1G54280.1 | haloacid dehalogenase-like hydrolase family protein
MARRRIRSRIRKSHFYTFRCLRPKTLDDQGPHVINGPGYTRIVHCNQPHLHLATKLIRYR
SNYVSTTRYNLLTFLPKCLYEQFHRVANFYFLVAAILSVFPLSPFNKWSMIAPLVFVVGL
SMGKEALEDWRRFMQDVEVNSRKASVHKGSGDFGRRTWKRIRVGDIVRVEKDEFFPADLL
LLSSSYEDGICYVETMNLDGETNLKVKRCLDATLALEKDESFQNFSGTIKCEDPNPNLYT
FVGNLECDGQVYPLDPNQILLRDSKLRNTAYVYGVVVFTGHDTKVMQNSTKSPSKRSRIE
KRMDYIIYTLFALLLTVSFISSLGFAVMTKLLMAEWWYLRPDKPESLTNPTNPLYAWVVH
LITALLLYGYLIPISLYVSIEVVKVLQAHFINQDLQLYDSESGTPAQARTSNLNEELGQV
DTILSDKTGTLTCNQMDFLKCSIAGTSYGVRASEVELAAAKQMAMDLEEKGEEVANLSMN
KGRTQRYAKLASKTSSDFELETVVTASDEKDQKQNTGVKGFSFEDNRLMNENWLNEPNSD
DILMFFRILAVCHTAIPEVDEDTGMCTYEAESPDEVAFLVASREFGFEFTKRTQSSVFIA
ERFSSSGQPVDREYKILNLLDFTSKRKRMSAIVRDEEGQILLLCKGADSIIFERLSKSGK
EYLGATSKHLNVYGEAGLRTLALGYRKLDETEYAAWNSEFHKAKTSVGADRDEMLEKVSD
MMEKELILVGATAVEDKLQKGVPQCIDNLAQAGLKIWVLTGDKMETAINIGYACSLLRQG
MKQISISLTNVEESSQNSEAAAKESILMQITNASQMIKIEKDPHAAFALIIDGKTLTYAL
KDDVKYQFLALAVDCASVICCRVSPKQKALVTRLAKEGTGKTTLAIGDGANDVGMIQEAD
IGVGISGVEGMQAVMASDFSIAQFRFLERLLVVHGHWCYKRIAQMICYFFYKNITFGLTL
FYFECFTGFSGQSIYNDSYLLLFNVVLTSLPVISLGVFEQDVPSDVCLQFPALYQQGPKN
LFFDWYRILGWMGNGVYASIVIFTLNLGIFHVQSFRSDGQTADMNAMGTAMFTCIIWAVN
VQIALTMSHFTWIQHVMIWGSIGAWYVFLALYGMLPVKLSGNIFHMLVEILAPAPIFWLT
SLLVIAATTLPYLFHISYQRSVNPLDHHIIQEIKHFRIDVEDERMWKREKSKAREKTKIG
FTARVDAKIRQLRGRLQRKHSVLSVMSGTSSNDTPSSNSQ*
>AT3G28360.1 | PGP16 (P-GLYCOPROTEIN 16) ATPase coupled to transmembrane movement of substances
MKTWGSMRSIFMHADGVDWMLMGLGLIGAVGDGFITPILFFITAMLLNDFGSFSFNDETF
MQPISKNALAMLYVACASWVICFLEGYCWTRTGERQAAKMRERYLRAVLRQDVGYFDLHV
TSTSDIITSVSSDSLVIQDFLSEKLPNILMNASAFVGSYIVGFMLLWRLTIVGFPFIILL
LIPGLMYGRALIGISRKIREEYNEAGSIAEQAISSVRTVYAFVSEKKMIEKFSDALQGSV
KLGLRQGLAKGIAIGSNGIVYAIWGFLTWYGSRMVMNYGYKGGTVSTVTVCVTFGGTALG
QALSNLKYFSEAFVAGERIQKMIKRVPDIDSDNLNGHILETIRGEVEFNNVKCKYPSRPE
TLIFDDLCLKIPSGKTVALVGGSGSGKSTVISLLQRFYDPNEGDILIDSVSINNMQVKWL
RSQMGMVSQEPSLFATSIKENILFGKEDASFDEVVEAAKASNAHNFISQFPHGYQTQVGE
RGVHMSGGQKQRIAIARALIKSPIILLLDEATSALDLESERVVQEALDNASVGRTTIVIA
HRLSTIRNADIICVLHNGCIVETGSHDKLMEIDGKYTSLVRLQQMKNEESCDNTSVGVKE
GRVSSLRNDLDYNPRDLAHSMSSSIVTNLSDSIPQDKKPLVPSFKRLMAMNRPEWKHALC
GCLSASLGGAVQPIYAYSSGLMISVFFLTNHEQIKENTRIYVLLFFGLALFTFFTSISQQ
YSFSYMGEYLTKRIREQMLSKILTFEVNWFDEEENSSGAICSRLAKDANVVRSLVGERMS
LLVQTISTVMVACTIGLVIAWRFTIVMISVQPVIIVCYYIQRVLLKNMSKKAIIAQDESS
KLAAEAVSNIRTITTFSSQERIMKLLERVQEGPRRESARQSWLAGIMLGTTQSLITCTSA
LNFWYGGKLIADGKMVSKAFFELFLIFKTTGRAIAEAGTMTTDLAKGSNSVDSVFTVLDR
RTTIEPENPDGYILEKIKGQITFLNVDFAYPTRPNMVIFNNFSIEIHEGKSTAIVGPSRS
GKSTVIGLIERFYDPLQGIVKIDGRDIRSYHLRSLRQHMSLVSQEPTLFAGTIRENIMYG
RASNKIDESEIIEAGKTANAHEFITSLSDGYDTYCGDRGVQLSGGQKQRIAIARTILKNP
SILLLDEATSALDSQSERVVQDALEHVMVGKTSVVIAHRLSTIQNCDTIAVLDKGKVVES
GTHASLLAKGPTGSYFSLVSLQRKVRYV*
>AT3G28390.1 | PGP18 (P-GLYCOPROTEIN 18) ATPase coupled to transmembrane movement of substances
MMKSFGSIRSIFMHADGVDWMLMALGLIGAVGDGFITPIIFFICSKLLNNVGGSSFDDET
FMQTVAKNAVALVYVACASWVICFIEGYCWTRTGERQAAKMREKYLKAVLRQDVGYFDLH
VTSTSDVITSVSSDSLVIQDFLSEKLPNFLMNTSAFVASYIVGFLLLWRLTIVGFPFIIL
LLIPGLMYGRALIRISMKIREEYNEAGSIAEQVISSVRTVYAFGSEKKMIEKFSTALQGS
VKLGLRQGLAKGIAIGSNGITYAIWGFLTWYGSRMVMNHGSKGGTVSSVIVCVTFGGTSL
GQSLSNLKYFSEAFVVGERIMKVINRVPGIDSDNLEGQILEKTRGEVEFNHVKFTYPSRP
ETPIFDDLCLRVPSGKTVALVGGSGSGKSTVISLLQRFYDPIAGEILIDGLPINKLQVKW
LRSQMGLVSQEPVLFATSIKENILFGKEDASMDEVVEAAKASNAHSFISQFPNSYQTQVG
ERGVQLSGGQKQRIAIARAIIKSPIILLLDEATSALDSESERVVQEALDNASIGRTTIVI
AHRLSTIRNADVICVVHNGRIIETGSHEELLEKLDGQYTSLVRLQQVDNKESDHISVEEG
QASSLSKDLKYSPKEFIHSTSSNIVRDFPNLSPKDGKSLVPSFKRLMSMNRPEWKHALYG
CLGAALFGAVQPIYSYSSGSMVSVYFLASHDQIKEKTRIYVLLFVGLALFTFLSNISQHY
GFAYMGEYLTKRIRERMLGKILTFEVNWFDKDENSSGAICSRLAKDANMVRSLVGDRMSL
LVQTISAVSITCAIGLVISWRFSIVMMSVQPVIVVCFYTQRVLLKSMSRNAIKGQDESSK
LAAEAVSNIRTITAFSSQERIINLLKMVQEGPRKDSARQSWLAGIMLGTSQSLITCVSAL
NFWYGGKLIADGKMMSKEFLEIFLIFASTGRVIAEAGTMTKDLVKGSDAVASVFAVLDRN
TTIEPENPDGYVPKKVKGQISFSNVDFAYPTRPDVIIFQNFSIDIEDGKSTAIVGPSGSG
KSTIISLIERFYDPLKGIVKIDGRDIRSCHLRSLRQHIALVSQEPTLFAGTIRENIMYGG
ASNKIDESEIIEAAKAANAHDFITSLSNGYDTCCGDRGVQLSGGQKQRIAIARAVLKNPS
VLLLDEATSALDSQSESVVQDALERLMVGRTSVVIAHRLSTIQKCDTIAVLENGAVVECG
NHSSLLAKGPKGAYFSLVSLQRTLF*
>AT1G27940.1 | PGP13 (P-GLYCOPROTEIN 13) ATPase coupled to transmembrane movement of substances
MDNTERSSNGNIQAETEAKEEKKNIKKESVSLMGLFSAADKLDYFLMLLGGLGACIHGAT
LPLFFVFFGKMLDSLGNLSTDPKAISSRVSQNALYLVYLGLVNFVSAWIGVSCWMQTGER
QTARLRINYLKSILAKDITFFDTEARDSNLIFHISSDAILVQDAIGDKTDHVLRYLSQFI
AGFVIGFLSVWQLTLLTLGVVPLIAIAGGGYAIVMSTISEKSETAYADAGKVAEEVMSQV
RTVYAFVGEEKAVKSYSNSLKKALKLGKRSGLAKGLGVGLTYSLLFCAWALLLWYASLLV
RHGKTNGAKAFTTILNVIFSGFALGQAAPSLSAIAKGRVAAANIFRMIGNNNSESSQRLD
EGTTLQNVAGRIEFQKVSFAYPSRPNMVFENLSFTIRSGKTFAFVGPSGSGKSTIISMVQ
RFYEPNSGEILLDGNDIKSLKLKWFREQLGLVSQEPALFATTIASNILLGKENANMDQII
EAAKAANADSFIKSLPNGYNTQVGEGGTQLSGGQKQRIAIARAVLRNPKILLLDEATSAL
DAESEKIVQQALDNVMEKRTTIVVAHRLSTIRNVDKIVVLRDGQVRETGSHSELMLRGGD
YATLVNCQETEPQENSRSIMSETCKSQAGSSSSRRVSSSRRTSSFRVDQEKTKNDDSKKD
FSSSSMIWELIKLNSPEWPYALLGSIGAVLAGAQTPLFSMGIAYVLTAFYSPFPNVIKRD
VEKVAIIFAGAGIVTAPIYLLQHYFYTLMGERLTSRVRLSLFSAILSNEIGWFDLDENNT
GSLTSILAADATLVRSALADRLSTIVQNLSLTVTALALAFFYSWRVAAVVTACFPLLIAA
SLTEQLFLKGFGGDYTRAYSRATSVAREAIANIRTVAAYGAEKQISEQFTCELSKPTKNA
FVRGHISGFGYGLSQFLAFCSYALGLWYVSVLINHKETNFGDSIKSFMVLIVTAFSVSET
LALTPDIVKGTQALGSVFRVLHRETKISPDQPNSRMVSQVKGDIEFRNVSFVYPTRPEID
IFKNLNLRVSAGKSLAVVGPSGSGKSTVIGLIMRFYDPSNGNLCIDGQDIKTLNLRSLRK
KLALVQQEPALFSTTIYENIKYGNENASEAEIMEAAKAANAHEFIIKMEEGYKTHAGDKG
VQLSGGQKQRVAIARAVLKDPSVLLLDEATSALDTSSEKLVQEALDKLMKGRTTVLVAHR
LSTIRKADTVAVLHKGRVVEKGSHRELVSIPNGFYKQLTSLQEVL*
>AT4G25960.1 | PGP2 (P-GLYCOPROTEIN 2) ATPase coupled to transmembrane movement of substances
MYISLIFFLSNHFPPLISIPIFIFLSFSSPTNYTHLKLKKMQPSGDPAPEKEKEMTQPKV
SLLKLFSFADFYDCVLMTLGSVGACIHGASVPIFFIFFGKLINIIGLAYLFPKQASHRVA
KYSLDFVYLSVAILFSSWLEVACWMHTGERQAAKMRRAYLRSMLSQDISLFDTEASTGEV
ISAITSDILVVQDALSEKVGNFLHYISRFIAGFAIGFTSVWQISLVTLSIVPLIALAGGI
YAFVAIGLIARVRKSYIKAGEIAEEVIGNVRTVQAFTGEERAVRLYREALENTYKYGRKA
GLTKGLGLGSMHCVLFLSWALLVWFTSVVVHKDIADGGKSFTTMLNVVIAGLSLGQAAPD
ISAFVRAKAAAYPIFKMIERNTVTKTSAKSGRKLGKVDGHIQFKDATFSYPSRPDVVIFD
RLNLAIPAGKIVALVGGSGSGKSTVISLIERFYEPISGAVLLDGNNISELDIKWLRGQIG
LVNQEPALFATTIRENILYGKDDATAEEITRAAKLSEAISFINNLPEGFETQVGERGIQL
SGGQKQRIAISRAIVKNPSILLLDEATSALDAESEKSVQEALDRVMVGRTTVVVAHRLST
VRNADIIAVVHEGKIVEFGNHENLISNPDGAYSSLLRLQETASLQRNPSLNRTLSRPHSI
KYSRELSRTRSSFCSERESVTRPDGADPSKKVKVTVGRLYSMIRPDWMYGVCGTICAFIA
GSQMPLFALGVSQALVSYYSGWDETQKEIKKIAILFCCASVITLIVYTIEHICFGTMGER
LTLRVRENMFRAILKNEIGWFDEVDNTSSMLASRLESDATLLKTIVVDRSTILLQNLGLV
VTSFIIAFILNWRLTLVVLATYPLVISGHISEKLFMQGYGGDLNKAYLKANMLAGESVSN
IRTVAAFCAEEKILELYSRELLEPSKSSFRRGQIAGLFYGVSQFFIFSSYGLALWYGSTL
MDKGLAGFKSVMKTFMVLIVTALAMGETLALAPDLLKGNQMVASVFEILDRKTQIVGETS
EELNNVEGTIELKGVHFSYPSRPDVVIFRDFDLIVRAGKSMALVGQSGSGKSSVISLILR
FYDPTAGKVMIEGKDIKKLDLKALRKHIGLVQQEPALFATTIYENILYGNEGASQSEVVE
SAMLANAHSFITSLPEGYSTKVGERGVQMSGGQRQRIAIARAILKNPAILLLDEATSALD
VESERVVQQALDRLMANRTTVVVAHRLSTIKNADTISVLHGGKIVEQGSHRKLVLNKSGP
YFKLISLQQQQQP*
>AT4G18050.1 | PGP9 (P-GLYCOPROTEIN 9) ATPase coupled to transmembrane movement of substances
MEEKSSKKNDGGNQKVSFFKLFSFADKTDVVLMTVGTIAAAGNGLTQPFMTLIFGQLINA
FGTTDPDHMVREVWKVAVKFIYLAVYSCVVAFLQVSCWMVTGERQSATIRGLYLKTILRQ
DIGYFDTETNTGEVIGRMSGDTILIQDAMGEKVGKFTQLLCTFLGGFAIAFYKGPLLAGV
LCSCIPLIVIAGAAMSLIMSKMAGRGQVAYAEAGNVVEQTVGAIRTVVAFTGEKQATEKY
ESKLEIAYKTVVQQGLISGFGLGTMLAVIFCSYGLAVWYGAKLIMEKGYNGGQVINVIFA
VLTGGMSLGQTSPSLNAFAAGRAAAFKMFETIKRSPKIDAYDMSGSVLEDIRGDIELKDV
YFRYPARPDVQIFAGFSLFVPNGKTVALVGQSGSGKSTVISLIERFYDPESGQVLIDNID
LKKLQLKWIRSKIGLVSQEPVLFATTIKENIAYGKEDATDQEIRTAIELANAAKFIDKLP
QGLDTMVGEHGTQMSGGQKQRLAIARAILKNPKILLLDEATSALDAESERIVQDALVNLM
SNRTTVVVAHRLTTIRTADVIAVVHQGKIVEKGTHDEMIQDPEGAYSQLVRLQEGSKEEA
TESERPETSLDVERSGSLRLSSAMRRSVSRNSSSSRHSFSLASNMFFPGVNVNQTDEMED
EENNVRHKKVSLKRLAHLNKPEIPVLVLGSIAAMVHGTVFPIFGLLLSSSINMFYEPAKI
LKKDSHFWALIYIALGLTNFVMIPVQNYFFGIAGGKLIKRIRSMCFDKVVHQEISWFDDT
ANSRSLVGDALALIVQNIATVTTGLIIAFTANWILALIVLALSPFIVIQGYAQTKFLTGF
SADAKAMYEEASQVANDAVSSIRTVASFCAEEKVMDLYQQKCDGPKKNGVRLGLLSGAGF
GFSFFFLYCINCVCFVSGAGLIQIGKATFGEVFKVFFALTIMAIGVSQTSAMAPDSNKAK
DSAASIFDILDSTPKIDSSSDEGTTLQNVNGDIEFRHVSFRYPMRPDVQIFRDLCLTIPS
GKTVALVGESGSGKSTVISMIERFYNPDSGKILIDQVEIQTFKLSWLRQQMGLVSQEPIL
FNETIRSNIAYGKTGGATEEEIIAAAKAANAHNFISSLPQGYDTSVGERGVQLSGGQKQR
IAIARAILKDPKILLLDEATSALDAESERVVQDALDRVMVNRTTVVVAHRLTTIKNADVI
AVVKNGVIAEKGRHETLMKISGGAYASLVTLHMSAN*
>AT1G28010.1 | PGP14 (P-GLYCOPROTEIN 14) ATPase coupled to transmembrane movement of substances
MDNIEPPFSGNIHAETEVKKEEKKKMKKESVSLMGLFSAADNVDYFLMFLGGLGTCIHGG
TLPLFFVFFGGMLDSLGKLSTDPNAISSRVSQNALYLVYLGLVNLVSAWIGVACWMQTGE
RQTARLRINYLKSILAKDITFFDTEARDSNFIFHISSDAILVQDAIGDKTGHVLRYLCQF
IAGFVIGFLSVWQLTLLTLGVVPLIAIAGGGYAIVMSTISEKSEAAYADAGKVAEEVMSQ
VRTVYAFVGEEKAVKSYSNSLKKALKLSKRSGLAKGLGVGLTYSLLFCAWALLFWYASLL
VRHGKTNGAKAFTTILNVIYSGFALGQAVPSLSAISKGRVAAANIFKMIGNNNLESSERL
ENGTTLQNVVGKIEFCGVSFAYPSRPNMVFENLSFTIHSGKTFAFVGPSGSGKSTIISMV
QRFYEPRSGEILLDGNDIKNLKLKWLREQMGLVSQEPALFATTIASNILLGKEKANMDQI
IEAAKAANADSFIKSLPNGYNTQVGEGGTQLSGGQKQRIAIARAVLRNPKILLLDEATSA
LDAESEKIVQQALDNVMEKRTTIVIAHRLSTIRNVDKIVVLRDGQVRETGSHSELISRGG
DYATLVNCQDTEPQENLRSVMYESCRSQAGSYSSRRVFSSRRTSSFREDQEKTEKDSKGE
DLISSSSMIWELIKLNAPEWLYALLGSIGAVLAGSQPALFSMGLAYVLTTFYSPFPSLIK
REVDKVAIIFVGAGIVTAPIYILQHYFYTLMGERLTSRVRLSLFSAILSNEIGWFDLDEN
NTGSLTSILAADATLVRSAIADRLSTIVQNLSLTITALALAFFYSWRVAAVVTACFPLLI
AASLTEQLFLKGFGGDYTRAYSRATSLAREAISNIRTVAAFSAEKQISEQFTCELSKPTK
SALLRGHISGFGYGLSQCLAFCSYALGLWYISVLIKRNETNFEDSIKSFMVLLVTAYSVA
ETLALTPDIVKGTQALGSVFRVLHRETEIPPDQPNSRLVTHIKGDIEFRNVSFAYPTRPE
IAIFKNLNLRVSAGKSLAVVGPSGSGKSTVIGLIMRFYDPSNGNLCIDGHDIKSVNLRSL
RKKLALVQQEPALFSTSIHENIKYGNENASEAEIIEAAKAANAHEFISRMEEGYMTHVGD
KGVQLSGGQKQRVAIARAVLKDPSVLLLDEATSALDTSAEKQVQEALDKLMKGRTTILVA
HRLSTIRKADTIVVLHKGKVVEKGSHRELVSKSDGFYKKLTSLQEAV*
>AT5G46540.1 | PGP7 (P-GLYCOPROTEIN 7) ATPase coupled to transmembrane movement of substances
MAEKAKKKKNGGGGNQRIAFYKLFTFADRYDIVLMVIGTLSAMANGLTQPFMSILMGQLI
NVFGFSDHDHVFKEVSKVAVKFLYLAAYAGVVSFLQVSCWMVTGERQSTRIRRLYLKTIL
RQDIGFFDTETNTGEVIGRMSGDTILIQDSMGEKVGKFTQLVSSFVGGFTVAFIVGMKLT
LALLPCVPLIVGTGGAMTYIMSKKAQRVQLAYTEAGNVVQQAVGSIRTVVAFTGEKQSMG
KYEKKLEIAYKSMVKQGLYSGLGIGIMMVVVYCTYGFAIWYGARQIIEKGYTGGQVMNVI
TSILTGGMALGQTLPSLNSFAAGTAAAYKMFETIKRKPKIDAYDMSGEVLEEIKGDIELR
DVYFRYPARPDVQIFVGFSLTVPNGMTVALVGQSGSGKSTVISLIERFYDPESGEVLIDG
IDLKKFQVKWIRSKIGLVSQEPILFATTIRENIVYGKKDASDQEIRTALKLANASNFIDK
LPQGLETMVGEHGTQLSGGQKQRIAIARAILKNPKILLLDEATSALDAESERIVQDALVK
LMLSRTTVVVAHRLTTIRTADMIAVVQQGKVIEKGTHDEMIKDPEGTYSQLVRLQEGSKK
EEAIDKEPEKCEMSLEIESSDSQNGIHSGTLTSPSGLPGVISLDQTEEFHENISSTKTQT
VKKGKEVSLRRLAHLNKPEISVLLLGSLAAVIHGIVFPVQGLLLSRTIRIFFEPSNKLKN
DSLFWALIFVALGLTDLIVIPLQNYLFAIAGAKLIKRIRSLSFDRVLHQDISWFDDTKNS
SGVIGARLSTDASTVKSIVGDVLGLIMQNMATIIGAFIIAFTANWLLALMALLVAPVMFF
QGYYQIKFITGFGAKARGKYEEASQVASDAVSSIRTVASFCAEDKVMDLYQEKCDEPKQQ
GFKLGLVSGLCYGGSYLALYVIESVCFLGGSWLIQNRRATFGEFFQVFFALTLTAVGVTQ
TSTMAPDINKAKDSAASIFDILDSKPKIDSSSEKGTILPIVHGDIELQHVSFRYPMRPDI
QIFSDLCLTISSGQTVALVGESGSGKSTVISLLERFYDPDSGKILLDQVEIQSLKLSWLR
EQMGLVSQEPVLFNETIGSNIAYGKIGGATEEEIITAAKAANVHNFISSLPQGYETSVGE
RGVQLSGGQKQRIAIARAILKDPKILLLDEATSALDAESERVVQDALDQVMVNRTTVVVA
HLLTTIKDADMIAVVKNGVIAESGRHETLMEISGGAYASLVAFNMSAN*
>AT1G02530.1 | PGP12 (P-GLYCOPROTEIN 12) ATPase coupled to transmembrane movement of substances
MNRDGAGEGDSVSHEHSTSKTDEKAKTVPLYKLFAFADSFDVFLMICGSLGAIGNGVCLP
LMTLLFGDLIDSFGKNQNNKDIVDVVSKVCLKFVYLGLGRLGAAFLQVACWMITGERQAA
KIRSNYLKTILRQDIGFFDVETNTGEVVGRMSGDTVHIQDAMGEKVGKFIQLVSTFVGGF
ALAFAKGWLLTLVMLTSIPFLAMAGAAMALLVTRASSRGQAAYAKAATVVEQTIGSIRTV
ASFTGEKQAINSYKKYITSAYKSSIQQGFSTGLGLGVMIYVFFSSYALAIWFGGKMILEK
GYTGGSVINVIIIVVAGSMSLGQTSPCVTAFAAGQAAAYKMFETIKRKPLIDAYDVNGKV
LGDIRGDIELKDVHFSYPARPDEEIFDGFSLFIPSGATAALVGESGSGKSTVINLIERFY
DPKAGEVLIDGINLKEFQLKWIRSKIGLVCQEPVLFSSSIMENIAYGKENATLQEIKVAT
ELANAAKFINNLPQGLDTKVGEHGTQLSGGQKQRIAIARAILKDPRVLLLDEATSALDTE
SERVVQEALDRVMVNRTTVVVAHRLSTVRNADMIAVIHSGKMVEKGSHSELLKDSVGAYS
QLIRCQEINKGHDAKPSDMASGSSFRNSNLNISREGSVISGGTSSFGNSSRHHSLNVLGL
FAGLDLGSGSQRVGQEETGTTSQEPLRKVSLTRIAALNKPEIPVLLLGTVVAAINGAIFP
LFGILISRVIEAFFKPADQLKKDSRFWAIIFVALGVTSLIVSPSQMYLFAVAGGKLIRRI
QSMCFEKAVHMEVSWFDEPENSSGTMGARLSTDAALIRALVGDALSLAVQNAASAASGLI
IAFTASWELALIILVMLPLIGINGFLQVKFMKGFSADAKSKYEEASQVANDAVGSIRTVA
SFCAEEKVMQMYNKQCEGPIKDGVKQGFISGLGFGFSFFILFCVYATSFYAAARLVEDGK
TTFIDVFQVFFALTMAAIGISQSSTFAPDSSKAKVAAASIFAIIDRKSKIDSSDETGTVL
ENVKGDIELRHLSFTYPARPGIQIFRDLCLTIRAGKTVALVGESGSGKSTVISLLQRFYD
PDSGQITLDGVELKKLQLKWLRQQMGLVGQEPVLFNDTIRANIAYGKGSEEAATESEIIA
AAELANAHKFISSIQQGYDTVVGEKGIQLSGGQKQRVAIARAIVKEPKILLLDEATSALD
AESERLVQDALDRVIVNRTTVVVAHRLSTIKNADVIAIVKNGVIAENGTHETLIKIDGGV
YASLVQLHMTASN*
>AT4G01820.1 | PGP3 (P-GLYCOPROTEIN 3) ATPase coupled to transmembrane movement of substances
MEEKTKTVPFYKLFSFSDSTDVLLMIVGSIGAIGNGVGFPLMTLLFGDLIDSIGQNQSNK
DIVEIVSKVCLKFVYLGLGTLGAAFLQVACWMITGERQAARIRSLYLKTILRQDIGFFDV
ETSTGEVVGRMSGDTVLILEAMGEKVGKFIQLIATFVGGFVLAFVKGWLLTLVMLVSIPL
LAIAGAAMPIIVTRASSREQAAYAKASTVVEQTLGSIRTVASFTGEKQAMKSYREFINLA
YRASVKQGFSMGLGLGVVFFVFFCSYALAIWFGGEMILKKGYTGGEVVNVMVTVVASSMS
LGQTTPCLTAFAAGKAAAYKMFETIERKPSIDAFDLNGKVLEDIRGEIELRDVCFSYPAR
PMEEVFGGFSLLIPSGATAALVGESGSGKSSVISLIERFYDPSSGSVLIDGVNLKEFQLK
WIRGKIGLVSQEPVLFSSSIMENIGYGKENATVEEIQAAAKLANAANFIDKLPRGLETLV
GEHGTQLSGGQKQRIAIARAILKDPRILLLDEATSALDAESERVVQEALDRVMMSRTTVI
VAHRLSTVRNADMIAVIHRGKIVEEGSHSELLKDHEGAYAQLIRLQKIKKEPKRLESSNE
LRDRSINRGSSRNIRTRVHDDDSVSVLGLLGRQENTEISREQSRNVSITRIAALNKPETT
ILILGTLLGAVNGTIFPIFGILFAKVIEAFFKPPHDMKRDSRFWSMIFVLLGVASLIVYP
MHTYLFAVAGGRLIQRIRVMCFEKVVHMEVGWFDDPENSSGTIGSRLSADAALIKTLVGD
SLSLSVKNAAAAVSGLIIAFTASWKLAVIILVMIPLIGINGYLQIKFIKGFTADAKAKYE
EASQVANDAVGSIRTVASFCAEEKVMEMYKKRCEDTIKSGIKQGLISGVGFGISFFVLYS
VYASCFYVGARLVKAGRTNFNDVFQVFLALTMTAIGISQASSFAPDSSKAKGAAASIFGI
IDGKSMIDSRDESGLVLENVKGDIELCHISFTYQTRPDVQIFRDLCFAIRAGQTVALVGE
SGSGKSTVISLLQRFYDPDSGHITLDRVELKKLQLKWVRQQMGLVGQEPVLFNDTIRSNI
AYGKGGDEASEAEIIAAAELANAHGFISSIQQGYDTVVGERGIQLSGGQKQRVAIARAIV
KEPKILLLDEATSALDAESERVVQDALDRVMVNRTTVVVAHRLSTIKNADVIAVVKNGVI
VEKGTHETLINIEGGVYASLVQLHISASS*
>AT4G01830.1 | PGP5 (P-GLYCOPROTEIN 5) ATPase coupled to transmembrane movement of substances
MKKGNLEANTKTVPFYKLFFFSDSTDVLLMIVGSIGAIANGVCSPLMTLLFGELIDAMGP
NQNNEEIVERVSKVCLSLVYLGLGALGAAFLQVACWMITGERQAARIRSLYLKTILRQDI
GFFDVEMTTGEVVGRMSGDTVLILDAMGEKVGKFIQLISTFVGGFVIAFLRGWLLTLVML
TSIPLLAMSGAAIAIIVTRASSQEQAAYAKASNVVEQTLGSIRTVASFTGEKQAMSSYKE
LINLAYKSNVKQGFVTGLGLGVMFLVFFSTYALGTWFGGEMILRKGYTGGAVINVMVTVV
SSSIALGQASPCLTAFTAGKAAAYKMFETIEREPLIDTFDLNGKVLEDIRGEIELRDVCF
SYPARPKEEVFGGFSLLIPSGTTTALVGESGSGKSTVISLIERFYDPNSGQVLIDGVDLK
EFQLKWIRGKIGLVSQEPVLFSSSIMENIGYGKEGATVEEIQAASKLANAAKFIDKLPLG
LETLVGEHGTQLSGGQKQRIAIARAILKDPRILLLDEATSALDAESERVVQEALDRIMVN
RTTVIVAHRLSTVRNADIIAVIHRGKIVEEGSHSELLKDHEGAYSQLLRLQEINKESKRL
EISDGSISSGSSRGNNSTRQDDDSFSVLGLLAGQDSTKMSQELSQKVSFTRIAALNKPEI
PILILGTLVGAVNGTIFPIFGILFAKVIEAFFKAPHELKRDSRFWSMIFVLLGVAAVIVY
PTTNYLFAIAGGRLIRRIRSMCFEKVVHMEVGWFDEPGNSSGAMGARLSADAALIRTLVG
DSLCLSVKNVASLVTGLIIAFTASWEVAIIILVIIPFIGINGYIQIKFMKGFSADAKAKY
EEASQVANDAVGSIRTVASFCAEEKVMEMYKKRCEDTIKSGIKQGLISGVGFGISFFVLY
SVYASCFYVGARLVKAGRTNFNDVFQVFLALTLTAVGISQASSFAPDSSKGKGAAVSIFR
IIDRISKIDSRDESGMVLENVKGDIELCHISFTYQTRPDVQVFRDLCLSIRAGQTVALVG
ESGSGKSTVISLLQRFYDPDSGHITLDGVELKKLRLKWLRQQMGLVGQEPVLFNDTIRAN
IAYGKGGEEATEAEIIAASELANAHRFISSIQKGYDTVVGERGIQLSGGQKQRVAIARAI
VKEPKILLLDEATSALDAESERVVQDALDRVMVNRTTIVVAHRLSTIKNADVIAVVKNGV
IAEKGTHETLINIEGGVYASLVQLHINASN*
>AT3G44630.3 | disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL
PPESSRAFSLSLSHSPFLSLCLMDWLMIRFLLMGFRCVSS*
>AT3G44630.3 | disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL
PPESSRAFSLSLSHSPFLSLCLMDWLMIRFLLMGFRCVSS*
>AT3G44630.3 | disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL
PPESSRAFSLSLSHSPFLSLCLMDWLMIRFLLMGFRCVSS*
>AT3G44630.2 | disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL
PPESSRVFLARTTV*
>AT3G44630.2 | disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL
PPESSRVFLARTTV*
>AT3G44630.2 | disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL
PPESSRVFLARTTV*
>AT3G44630.1 | disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL
PPESSRVFLARTTV*
>AT3G44630.1 | disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL
PPESSRVFLARTTV*
>AT3G44630.1 | disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL
PPESSRVFLARTTV*